Table 3 Clinical and laboratory characteristics, management and outcome of 226 patients with RSV infection
Parameter | Number of patients (%) |
|---|---|
Presenting symptom | |
Cough | 196 (86.7) |
Difficulty in breathing (tight chest) | 115 (50.9) |
Fever | 91 (41.6) |
Nasal congestion | 67 (29.6) |
Runny nose | 35 (15.4) |
Vomiting | 26 (11.5) |
Wheeze | 20 (8.8) |
Apnoea | 12 (5.3) |
Inflammatory and haematological markers | |
Median CRP (mg/L) | 12.3 |
Median WCC (x 109/L) | 11.1 |
Median percent band cell count | 8.0 |
Median Haemoglobin concentration (g/dL) | 11.0 |
Median platelet count (x 109/L) | 410 |
Treatment | |
Supplemental oxygen | 170 (75.2) |
Bronchodilators | 150 (66.4) |
Assisted ventilation | N = 59 (26.1) |
CPAP | 43 (19.0) |
IPPV | 16 (7.1) |
Antibiotics | N = 221 (97.8) |
Intravenous | 174 (78.7) |
Oral | 47 (21.3) |
Presence of co-pathogens | 70 (31.1) |
Care level | N = 89 (39.4) |
ICU | 47 (20.8) |
High care | 38 (16.8) |
Both ICU and high care | 4 (1.8) |
Outcome | |
Discharged | 170 (75.2) |
Transferred to another hospital | 54 (23.9) |
Died | 2 (0.9) |